Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • PharmaTutor
    28 April 2010

    PCI warns pharmacy colleges planning to launch 2nd shift for B Pharm

    The Pharmacy Council of India (PCI), the statutory body governing the pharmacy education in the country, has warned against the move by some of the institutes to start a second shift for pharmacy courses. PCI said that it would not approve such courses or students taking such courses as per the Pharmacy Act, 1948.

  • 28 April 2010
    Cytomegalovirus Resistance Linked to Subtherapeutic Ganciclovir

    The resistance of cytomegalovirus (CMV) to ganciclovir prophylaxis might be related to subtherapeutic levels of the antiviral agent, according to investigators from Loyola University Medical Center in Maywood, Illinois.

    Although the study was small, the findings sparked a lively discussion among those attending the session on transplant infections at the International Society for Heart & Lung Transplantation 30th Anniversary Meeting.

    [adsense:336x280:8701650588]

  • 28 April 2010
    HPV Testing May Detect More Precancerous Cells Than Conventional Cytology

    As part of a well-established organized screening program, primary human papillomavirus (HPV) screening with cytology triage is more sensitive than conventional cytology in the detection of cervical intraepithelial neoplasia (CIN) grade III, according to the results of a randomized trial reported online April 28 in the BMJ.

  • 27 April 2010
    State FDA lists 44 drug samples as not-of-standard drugs in March

    Maharashtra Food and Drug Administration (FDA) has found 44 drugs not-of-standard-quality during its inspection in March 2010. Most of the not-of-standard-quality drugs were from tax-holiday states Himachal Pradesh and Uttaranchal. And every month, the number of sub-standard drug samples keeps increasing and firms from these two states have major share in this list.

  • 27 April 2010
    Work for vaccine production started in 2 PSUs, BCG Lab in Chennai yet to get green signal

    Even as two of the three PSUs, CRI in Kasauli and PII in Coonoor, have run into action within two months of accepting the order of resumption of vaccine production from the Union Health Ministry on February 26 this year, the BCG Vaccine Lab in Chennai is still waiting for approval from authorities to commence operations, it is learnt.

  • 27 April 2010
    Glenmark's oral contraceptive gets FDA nod

    Glenmark's US subsidiary Glenmark Generics has been granted approval by the United States Food and Drug Administration (FDA) for Norethindrone tablets 0.35mg—its generic version of Nor-QD. The product will be marketed under the trade name Heather and distribution is expected to start immediately.

  • 26 April 2010
    AIIMS to conduct conference on care of children born with cleft lip, palate & craniofacial anomalies

    The All India Institute of Medical Sciences (AIIMS), New Delhi is hosting a conference on the care of children born with cleft lip, palate and craniofacial anomalies. The programme is part of the ninth Annual Conference of the Indian Society of Cleft Lip palate and Craniofacial Anomalies which is being held in New Delhi from April 23 to April 25.

  • 26 April 2010
    Indian pharma companies will become product companies, Reinhard Gluck, Cadila, India

    The foremost challenge for any pharma company with biotech divisions or units in the Asian region is bringing out the product. We do not have too many products. However, I have been convinced that at least some Indian companies will do it.

  • 26 April 2010
    Liraglutide Superior to Sitagliptin When Added to Metformin for Glycemic Control

    The addition of a glucagonlike peptide-1 (GLP-1) agonist in patients with inadequate glycemic control when treated with metformin alone resulted in significantly larger reductions in HbA1c levels when compared with the addition of a dipeptidyl peptidase-4 (DPP-4) inhibitor, a new study has shown.

  • 26 April 2010
    FDA Launches Campaign to Improve Infusion-Pump Safety

    The US Food and Drug Administration (FDA) today unveiled an ambitious campaign to improve the safety of external infusion pumps, which have triggered 56,000 FDA adverse event reports linked to more than 500 deaths and 87 product recalls from 2005 through 2009, according to the agency.

    The campaign mostly affects the makers of external infusion pumps, which may find FDA inspectors visiting their plants to ensure that safe manufacturing and testing processes are in place.

Subscribe to Pharma News